Al-Batran, S., Van Cutsem, E., Oh, S. C., Bodoky, G., Shimada, Y., Hironaka, S., . . . Wilke, H. (2016). Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma(†). Ann Oncol.
Čikaški stil citiranjaAl-Batran, S.-E., et al. "Quality-of-life and Performance Status Results From the Phase III RAINBOW Study of Ramucirumab Plus Paclitaxel Versus Placebo Plus Paclitaxel in Patients With Previously Treated Gastric or Gastroesophageal Junction Adenocarcinoma(†)." Ann Oncol 2016.
MLA način citiranjaAl-Batran, S.-E., et al. "Quality-of-life and Performance Status Results From the Phase III RAINBOW Study of Ramucirumab Plus Paclitaxel Versus Placebo Plus Paclitaxel in Patients With Previously Treated Gastric or Gastroesophageal Junction Adenocarcinoma(†)." Ann Oncol 2016.